A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 462
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : sPAP
Long Form : systolic pulmonary artery pressure
No. Year Title Co-occurring Abbreviation
2022 Impact of Pulmonary Hypertension on Outcomes in Patients With Mitral Annular Calcium and Associated Mitral Valve Dysfunction. MAC, MV
2022 The clinical experience of macitentan in pulmonary hypertension in Indian cohort: 12-month follow-up. ERA, PAH, TAPSE, WHO-FC
2021 Age-changes in right ventricular function-pulmonary circulation coupling: from pediatric to adult stage in 1899 healthy subjects. The RIGHT Heart International NETwork (RIGHT-NET). BSA, RIGHT-NET, SV, TAPSE
2021 Assessment of Pulmonary Artery Pressures by Various Doppler Echocardiographic Parameters and its Correlation with Cardiac Catheterization in Patients with Pulmonary Hypertension. mPAP, PH, PR, RHC, RVOT AcT, TR
2021 Association of Pulmonary Hypertension With Inflammatory Markers and Volume Status in Hemodialysis Patients of End-Stage Renal Disease. PH
2021 CD21low B cells are predictive markers of new digital ulcers in systemic sclerosis. AUC, CI, mRSS
2021 Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism. CTEPH, PH
2021 Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension. CI, HDA, HF, HFrEF, IRB, LV, LVCI, PCWP, PH, RHC, RV
2021 Comorbidities of Patients With Idiopathic Pulmonary Fibrosis in Four Latin American Countries. Are There Differences by Country and Altitude? IPF, LA, PH
10  2021 Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure. AHF, FGF23, hs-TnT, NT-proBNP, sST2
11  2021 Early echocardiographic findings in patients hospitalized for COVID-19 pneumonia: a prospective, single center study. ---
12  2021 Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis. 99mTc-DPD, CA, CMR, LS, LV, RV, ST, TAPSE, TTR
13  2021 Easily available ECG and echocardiographic parameters for prediction of left atrial remodeling and atrial fibrillation recurrence after pulmonary vein isolation: A multicenter study. AF, APWD, HR, LA, LVS, PVI
14  2021 Echocardiographic Assessment of Right Ventricular-Arterial Coupling in Predicting Prognosis of Pulmonary Arterial Hypertension Patients. CEP, mPAP, PAH, RV
15  2021 Echocardiographic predictors of exercise induced pulmonary hypertension in patients with asymptomatic moderate to severe mitral regurgitation and preserved left ventricular ejection fraction. EIPH, EROA, MR, PH
16  2021 Echocardiographic Right Ventricular Outflow Track Notch Formation and the Incidence of Acute Mountain Sickness. AMS, CI, OR, PAP, RVOT
17  2021 Estimated glomerular filtration rate and renal resistive index as possible predictive markers of mortality in systemic sclerosis. CKD-EPI, DAI, eGFR, FVC, RRI, SSc
18  2021 Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database. eGFR, EUSTAR, OS, SRC, SSc
19  2021 Evaluation of Left Ventricular Diastolic Function by 2-D Speckle Tracking Echocardiography in Patients with Connective Tissue Disease-Associated Pulmonary Artery Hypertension. CTD, PAH, SR, SRe
20  2021 Evaluation of the Relationship Between Pulmonary Artery Hypertension and Esophageal Varices Bleeding in Transplantation Candidates. EVB, MELD, PHT, TTE
21  2021 Exercise-induced pulmonary hypertension in HIV patients: Association with poor clinical and immunological status. AIDS, ART, ESE, Ex-PH, HIV, PAH
22  2021 Extravascular lung water and cardiac function assessed by echocardiography in healthy lowlanders during repeated very high-altitude exposure. EVLW, HA, LA
23  2021 Feasibility and Role of Right Ventricular Stress Echocardiography in Adult Patients. FAC, RV, SE, TAPSE
24  2021 Identification of novel metabolic signatures potentially involved in the pathogenesis of COPD associated pulmonary hypertension. COPD, EBC, ERS, ESC, NMR
25  2021 Imaging data in COVID-19 patients: focused on echocardiographic findings. TAPSE
26  2021 Impact of pulmonary hypertension on arteriovenous fistula failure of hemodialysis patients: A 10 years follow-up cohort study. AVF, ESRD, MHD, PH
27  2021 Impact of sacubitril/valsartan on systolic heart failure: Right heart location and clustering analysis. FAC, HF, HFrEF, LV, LVEF, MACEs, RV, TAPSE
28  2021 Long term effects of mild severity COVID‑19 on right ventricular functions. COVID-19, CRP, NLR, PLR, RV, RVFAC, RVGLS, RVMPI, STE, TAPSE
29  2021 Natural course of tricuspid regurgitation and prognostic implications. LVEF, RV, TR
30  2021 NeoAPACHE II. Relationship Between Radiographic Pulmonary Area and Pulmonary Hypertension, Mortality, and Hernia Recurrence in Newborns With CDH. CDH
31  2021 New echocardiographic indices of shift to biventricular failure to optimize risk stratification of chronic heart failure. fwRVLS, HF, LA, LV, PALS, RV, STE
32  2021 Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction. BMI, LVEF, MACE, PH
33  2021 Outcome of aortic stenosis according to invasive cardiac damage staging after transcatheter aortic valve replacement. AS, LVEDP, PCWP, RAP, TAVR
34  2021 Outcomes and Risk Factors of Systolic Pulmonary Artery Pressure Progression in Patients with Systemic Rheumatic Diseases: Follow-up Results from a Korean Registry. IQR, MCTD, RA
35  2021 Predictive echocardiographic factors of severe obstructive sleep apnea. AHI, FS, IVS, LV, LVED, LVEF, LVES, OSA, RVID, TTE
36  2021 Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases. CTD-ILD, HRCT, IPF, PF-ILD
37  2021 Preload dependence of pulmonary haemodynamics and right ventricular performance. FTR, HD, RV
38  2021 Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up. iASD, iASDs, MV, TEE, TEER, TTE
39  2021 Prognostic significance of right ventricular function during exercise in asymptomatic/minimally symptomatic patients with nonobstructive hypertrophic cardiomyopathy. ESE, Ex-TAPSE, HCM, LVOT, NHCM, PA, RV
40  2021 Prognostic Value of Peak Exercise Systolic Pulmonary Arterial Pressure in Asymptomatic Primary Mitral Valve Regurgitation. MR
41  2021 Prognostic values of exercise echocardiography and cardiopulmonary exercise testing in patients with primary mitral regurgitation. CPX, ExE, HR, LVEF, ME, MR
42  2021 Pulmonary artery obstruction index, pulmonary artery diameter and right ventricle strain as prognostic CT findings in patient with acute pulmonary embolism. PAD, PAOI, PCTA, PE, RV
43  2021 Pulmonary Hypertension in Children with Ventricular Septal Defects. PH, VSD
44  2021 Right Atrial Strain in the Assessment of Right Heart Mechanics in Patients with Heart Failure with Reduced Ejection Fraction. HFrEF, LVEF, PVR, RA, RAP, RHC, RV, RVEDP
45  2021 Serum Thiol Levels and Thiol/Disulfide Homeostasis in Patients with Rheumatic Mitral Valve Disease and Healthy Subjects. LA, RHD, RMVD
46  2021 Structural and Functional Characteristics of Mitral Paravalvular Leakage Identified by Multimodal Imaging and Their Implication on Clinical Presentation. CT, LA, LDH, PVL
47  2021 The effects of interventional mitral valve repair using the MitraClip System on the results of pulmonary function testing, pulmonary pressure and diffusing capacity of the lung. DLCO, FEV1, LAD, LVEF, MR, RV, TLC, VC
48  2021 The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients. AUC, CRP, EF, MASa, PH, PTH, RRT, TDE
49  2021 The right ventricle of transplanted hearts at 2,640 meters above sea level. A latin-american experience. masl, RV
50  2021 Tricuspid regurgitation in ischemic mitral regurgitation patients: prevalence, predictors for outcome and long-term follow-up. FTR, IMR, LVEF, LVIDD
51  2021 Ultraprotective ventilation allowed by extracorporeal CO2 removal improves the right ventricular function in acute respiratory distress syndrome patients: a quasi-experimental pilot study. ARDS, ECCO2R, RV, TAPSE, TTE, VT, VTIAo
52  2020 A canonical correlation analysis of the relationship between clinical attributes and patient-specific hemodynamic indices in adult pulmonary hypertension. CCA, CFD, CO, dPAP, PH, RV, SV
53  2020 A new risk model for the evaluation of the thromboembolic milieu in patients with atrial fibrillation: the PALSE score. AF, LA, LVEF, SEC
54  2020 Acute and short term effects of successful mitral valvuloplasty on net atrio ventricular compliance and its correlation with clinical outcome. 6MWT, BMV, Cn, EC, FC, NYHA
55  2020 Association of digoxin therapy with case fatality rate in acute pulmonary embolism. BNP, PESI, RV
56  2020 Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm. MPNs, OR, PH
57  2020 Associations between geographical environment and systolic pulmonary arterial pressure of Chinese adults: impact analysis and predictive modeling. PLSR
58  2020 BMI Is Causally Associated With Pulmonary Artery Pressure But Not Hemodynamic Evidence of Pulmonary Vascular Remodeling. hpGRS, PAH, PAP, PVH, RHC, sGRS
59  2020 Caregiver Burden in Patients with Pulmonary Hypertension. PH, QoL, WHO
60  2020 Changes in ET-1, Plasma Neuropeptide Y, and CGRP in Child Patients With Congenital Heart Disease Complicated With Pulmonary Hypertension Before and After Operation. CGRP, CHD, ET-1, PH
61  2020 Correlation between Doppler echocardiography and right heart catheterization assessment of systolic pulmonary artery pressure in patients with severe aortic stenosis. AS, PH, RHC
62  2020 Does the volume overload exaggerate the severity of mitral regurgitation in patients with decompensated heart failure? EROA, HF, MR, proBNP, RV, VC
63  2020 Echocardiographic assessment of the right ventricle and its correlation with patient outcome in acute respiratory distress syndrome. ARDS, RVFAC, TAPSE, TTE
64  2020 Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude. 2D-STE, CPAP, CRP, OSAS, PVR, RT3DE, RV
65  2020 Functional tricuspid regurgitation of degenerative mitral valve disease: a crucial determinant of survival. AFib, DMR, EF, FTR
66  2020 Hormonal deficiencies in heart failure with preserved ejection fraction: prevalence and impact on diastolic dysfunction: a pilot study. DHEAS, HFpEF, TAPSE, TPV
67  2020 Immediate and Short-Term Outcome of Percutaneous Atrial Septal Defects Closure in Adult Patients. FC, FC, NICVD, NYHA
68  2020 Impact of prosthesis-patient mismatch on early and late outcomes after mitral valve replacement: a meta-analysis. AF, MVR, PH, PPM, TPG
69  2020 Increased Plasma Level of miR-210 as a Potential Diagnostic Marker for Chronic Obstructive Pulmonary Disease Induced Pulmonary Hypertension. COPD, FVC, PH
70  2020 Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension. ELISA, HCs, IHC, IL-32, IPAH, mPAP, mRSS, PAH, RHC, ROC, SSc
71  2020 Prediction of pulmonary hypertension in older adults based on vital capacity and systolic pulmonary artery pressure. AUC, PH, RHC, ROC
72  2020 Preserved right ventricular function but increased right atrial contractile demand in altitude-induced pulmonary hypertension. RA, RV
73  2020 Prevalence and factors associated with pulmonary arterial hypertension on maintenance hemodialysis patients in Kinshasa, Democratic Republic of Congo: a cross-sectional study. PAH
74  2020 Prevalence and outcomes of pulmonary hypertension after percutaneous closure of atrial septal defect: a systematic review and meta-analysis. ASD, PH
75  2020 Prognostic Significance of Red Cell Distribution Width in Idiopathic Pulmonary Fibrosis and Combined Pulmonary Fibrosis Emphysema. 6MWT, CPFE, IPF, RDW
76  2020 Pulmonary arterial pressure and nasal obstruction in mouth-breathing children: Similarities between adenotonsillar hypertrophy and allergic rhinitis. AR, ATH, MB, NP
77  2020 Pulmonary arterial pressure in at-term in vitro fertilization neonates: A cross-sectional study. IVF
78  2020 Pulmonary artery pressures and outcomes after MitraClip. PHT
79  2020 Pulmonary Artery Systolic Pressure Response to Exercise in Patients with Rheumatic Mitral Stenosis: Determinants and Prognostic Value. MS
80  2020 Pulmonary function tests at low altitude predict pulmonary pressure response to short-term high altitude exposure. HA, LA, OR, PAP, PVR
81  2020 Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15-year prospective longitudinal trajectories in survivors. HF, PH, RVD, TAPSE
82  2020 Pulmonary hypertension in end-stage renal disease patients on dialysis and predialysis patients. CI, CO, ESRD, HD, PD, PH
83  2020 Pulmonary Hypertension in Patients Starting Peritoneal Dialysis. CKD, LV, LVF, PD, PH, RRF
84  2020 Rapid Ascent to 4559 m Is Associated with Increased Plasma Components of the Vascular Endothelial Glycocalyx and May Be Associated with Acute Mountain Sickness. AMS, ICAM-1
85  2020 Reduced pulmonary vascular reserve during stress echocardiography in confirmed pulmonary hypertension and patients at risk of overt pulmonary hypertension. AcT, CO, ESE, PH, PVRI, TRV
86  2020 Relationship between CHA2DS2-VASc and CHADS2 scores with pulmonary hypertension in patients with acute pulmonary embolism. PE, PH
87  2020 Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. AS, FAC, HF, RV, RVLS, TAPSE, TAVI
88  2020 Screening for precapillary pulmonary hypertension in chronic myeloproliferative disorders: the role of N-terminal pro-B-type natriuretic peptide and vascular endothelial growth factor - a pilot study. LH, MPN, NT-proBNP, PH, VEGF
89  2020 Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review. PAH, SLR, SSc, TRV
90  2020 Severity of acute respiratory distress syndrome and echocardiographic findings in clinical practice-an echocardiographic pilot study. RV
91  2020 Short-term effects of sildenafil in the treatment of dogs with pulmonary hypertension secondary to degenerative mitral valve disease. DMVD, PH
92  2020 Subclinical impairment of dynamic left ventricular systolic and diastolic function in patients with obstructive sleep apnea and preserved left ventricular ejection fraction. EF, GLS, LV, OB, OSA
93  2020 Surgical Pulmonary Embolectomy Outcomes for Acute Pulmonary Embolism. CI, PE
94  2020 The effect of global longitudinal strain on mpaired six-minute walk test performance in patients with sarcoidosis. GLS
95  2020 The Renal Resistive Index: A New Biomarker for the Follow-up of Vascular Modifications in Systemic Sclerosis. DLCO, FVC, NVC, PAH, RRI, SSc
96  2020 The tricuspid annular plane systolic excursion to systolic pulmonary artery pressure index: Association with all-cause mortality in patients with moderate or severe tricuspid regurgitation. HR, RV, TAPSE, TR
97  2020 Value of Echocardiographic Right Ventricular and Pulmonary Pressure Assessment in Predicting Transcatheter Tricuspid Repair Outcome. RV, TAPSE, TTVR
98  2020 [Association between serum levels of osteopontin and systolic pulmonary artery pressure among healthy adults post acute high altitude exposure]. MDA, OPN, SOD
99  2020 [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease]. 6MWD, BNP, CD, CI, ES, mPAP, mRAP, NYHA, PAH-CHD, PVR, SD, SP
100  2019 A new algorithm for optimization of rate-adaptive pacing improves exercise tolerance in patients with HFpEF. 6mWT, AF, CPET, DASI, ECHO, HFpEF, PASE